+44 (0)24 7671 8970
More publications     •     Advertise with us     •     Contact us
 
Loading...
News Article

Evonetix places first DNA Synthesis Development Platform at Imperial College London

News

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.

EVONETIX, the company developing semiconductor scale technology to improve access to gene synthesis, has announced its first placement of a DNA synthesis development platform for evaluation at Imperial College London. This is the Company’s first platform to be installed in an external scientific setting; a significant milestone as it continues to optimize its gene synthesis technology in preparation for customer use and commercialization.

The platform has been placed in labs led by Dr Marko Storch, Head of Synthetic Biology and Automation, London Biofoundry, and Professor Paul Freemont, Head of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London. The installation of this platform follows the delivery of Evonetix’s chip-synthesized DNA for evaluation to Dr Jenny Molloy, Co-chair of the Engineering Biology Interdisciplinary Research Centre at the University of Cambridge earlier this year.

Evonetix’s DNA synthesis platform combines patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, bringing novel approaches to chemistry and process control to enable DNA synthesis on the benchtop of any lab. Better access to gene-length DNA will be transformative for engineering biology research, with applications across the healthcare, biotech, agriculture, and food industries.

Colin McCracken, Chief Executive Officer at Evonetix, said: “Reaching this major milestone demonstrates continued confidence in the progress of our technology and represents a significant step forward in delivering on our vision to place benchtop gene synthesis into the hands of all researchers.”

Dr Marko Storch, Head of Synthetic Biology and Automation, London Biofoundry, Imperial College London, commented: “Evonetix’s platform is an exciting new development in DNA synthesis, and we are delighted to have the opportunity to host it in our lab. Rapid access to gene-length DNA synthesis will transform our research capabilities and drive the development of our sophisticated and innovative automation platforms and workflows to support cutting-edge synthetic biology research.”

Dr Paul Freemont, Head of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, added: “We are excited to be the first to receive Evonetix’s DNA synthesis platform. The limitations of the current service model for accessing long synthetic DNA, including turnaround time and costs, create barriers in our synthetic biology research. Evonetix’s technology has the potential to completely change the way we produce and use DNA, enabling flexibility and speed that will have a significant impact on the way we conduct our research into human disease and infection.”

SONOTEC and S3 Alliance join at SEMICON Europa
Luminaries like high-NA EUV and curvilinear photomasks
SensiML and Silicon Technology join forces
TRI launches high-performance 3D AXI
SONOTEC and S3 Alliance join at SEMICON Europa
Marquee Semiconductor expands Indian presence
Micron begins Memory Manufacturing Fab
SiLC Technologies advances Machine Vision
Renesas partners with EdgeCortix
Gradiant acquires H+E Group
Webinar: Hydrogen Generation Industry Innovations to Meet Expanding North American Fab Hydrogen Requirements
EdgeCortix set to disrupt the edge market?
Evonetix places first DNA Synthesis Development Platform at Imperial College London
ASE launches Integrated Design Ecosystem
Cohu acquires Equiptest Engineering
Advantest wins 2022 Best Supplier Award from ASE Holdings
SEMI welcomes new board members
Advanced Energy breaks ground on flagship factory
GlobalFoundries opens new Malaysia office
TSMC reveals 'breakthrough' set to redefine the future of 3D IC
Delphon announce new VP, strategic marketing & business development
Particle Measuring Systems Announces Acquisition of EMS
Ireland begins high-volume production of Intel 4 Technology
Advantest to showcase latest test solutions
200 gigabits per second
KemLab Inc. applauds CHIPS Act's commitment
200mm fabs to reach record capacity by 2026
Governor DeSantis dedicates $50 million for workforce development
DOD names eight 'Microelectronics Commons' Hubs
TSMC accelerates renewable energy adoption
Mouser signs global agreement with MediaTek
U.S. Government secures GlobalFoundries contract
×
Search the news archive

To close this popup you can press escape or click the close icon.
Logo
×
Logo
×
Register - Step 1

You may choose to subscribe to the Silicon Semiconductor Magazine, the Silicon Semiconductor Newsletter, or both. You may also request additional information if required, before submitting your application.


Please subscribe me to:

 

You chose the industry type of "Other"

Please enter the industry that you work in:
Please enter the industry that you work in: